Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02750397 · ClinicalTrials.gov registry record
HIV-to-HIV Transplant at MGH
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 13
- Enrollment target
NCT02750397: Completed study, sponsored by Massachusetts General Hospital.
NCT02750397 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02750397 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
HIV-infected (HIV+) individuals who agree to accept and receive a solid organ transplant from an HIV+ deceased donor will be followed to determine the safety and efficacy of this practice. HIV+ individuals who receive a solid organ transplant from HIV-uninfected donors will also be followed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2016-08 |
| Est. Completion | 2025-07-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02750397
The ClinicalTrials.gov registry entry for NCT02750397 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02750397 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02750397 about?
NCT02750397 is a clinical study titled "HIV-to-HIV Transplant at MGH". HIV-infected (HIV+) individuals who agree to accept and receive a solid organ transplant from an HIV+ deceased donor will be followed to determine the safety and efficacy of this practice. HIV+ individuals who receive a solid organ transplant from HIV-uninfected donors will also be followed.
What is the current status of trial NCT02750397?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2016-08. Estimated completion is 2025-07-16.
Who is sponsoring clinical trial NCT02750397?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.